Future Science Group
Browse
1/1
2 files

Supplementary Figures – Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

Download all (328.81 kB)
figure
posted on 2022-03-01, 09:35 authored by Figshare Future Science GroupFigshare Future Science Group, Xi Wang, Wenjing Zhong, Jiarong Yi, Haoming Wu, Xuxiazi Zou, Jikun Feng, Xinjian Huang, Siqi Li

Supplementary Figure 1. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

Survival curves stratified by adjuvant ET regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving OFS+TAM/AI (A,B), TAM (C,D) and AI (E,F)

Supplementary Figure 2. Androgen receptor expression and its prognostic value in T1N0 Luminal/HER2− breast cancer

Survival curves stratified by adjuvant CT regimen. Recurrence-free and distant recurrence-free survival according to androgen receptor (AR) expression in patients receiving AC (A,B), TC (C,D) and TAC (E,F)

Funding

National Natural Science Foundation of China (Grant No. 81972459 and No. 81772826).

History

Usage metrics

    Future Oncology

    Categories

    Keywords

    Breast cancer2 cm or smaller node-negative tumors (T1N0)Luminal/HER2−Androgen receptorAdjuvant therapy responsePrognostic factorsSurvivalCancer DiagnosisCancer GeneticsCancer Therapy (excl. Chemotherapy and Radiation Therapy)

    Licence

    CC BY-NC-ND 4.0

    Exports